Outcomes of Immunotherapy Treatment in Sinonasal Mucosal Melanoma
Approximately half of patients will have a local response following immunotherapy, but it is rare to have improvement at metastatic locations. Further research within our group will assess optimal timing and markers that are predictive of response.
Authors
- Jillian W. Lazor (ORCID: https://orcid.org/0000-0002-7966-9377)
- Garret W. Choby (ORCID: https://orcid.org/0000-0002-3745-2727)
- Tara C. Mitchell (ORCID: https://orcid.org/0000-0002-8186-7284)
- Edward C. Kuan (ORCID: https://orcid.org/0000-0003-3475-0718)
- Christopher H. Le (ORCID: https://orcid.org/0000-0002-7580-3030)
- Rijul S. Kshirsagar (ORCID: https://orcid.org/0000-0002-3113-2685)
- Carl Henry Snyderman (ORCID: https://orcid.org/0000-0002-8920-4522)
- Timothy L. Smith (ORCID: https://orcid.org/0000-0002-6424-7083)
- James N. Palmer (ORCID: https://orcid.org/0000-0002-7535-9339)
- Isaac P. Obermeyer (ORCID: https://orcid.org/0000-0003-1580-0345)
- Michelle Hong (ORCID: https://orcid.org/0000-0002-1897-8635)
- Jacob Harris (ORCID: https://orcid.org/0000-0001-6811-626X)
- Vivek C. Pandrangi
- Jeffrey D. Suh (ORCID: https://orcid.org/0009-0007-8303-639X)
- Eugene H. Chang (ORCID: https://orcid.org/0000-0002-9870-8220)
- Daniel M. Beswick (ORCID: https://orcid.org/0000-0001-8612-5442)
- Nicholas Fung (ORCID: https://orcid.org/0000-0001-7181-0834)
- Arash Abiri (ORCID: https://orcid.org/0000-0003-2656-1060)
- Brian J. Johnson (ORCID: https://orcid.org/0000-0003-4092-8164)
- Jivianne T. Lee (ORCID: https://orcid.org/0000-0002-0711-855X)
- Mathew Geltzeiler (ORCID: https://orcid.org/0000-0001-6553-3885)
- Nithin D. Adappa (ORCID: https://orcid.org/0000-0002-0339-8769)
- Jacob G. Eide (ORCID: https://orcid.org/0000-0003-3727-8287)
- Marilene B. Wang (ORCID: https://orcid.org/0000-0002-2799-6325)
- Carlos Pinheiro‐Neto (ORCID: https://orcid.org/0000-0003-3921-4658)
- Michael A. Kohanski (ORCID: https://orcid.org/0000-0001-8399-364X)
- Eric W. Wang (ORCID: https://orcid.org/0000-0002-1180-5854)
- Seyed Ali Nabavizadeh
Institutions
- Mayo Clinic (US)
- University of Arizona (US)
- Henry Ford Health System (US)
- University of California, Los Angeles (US)
- Oregon Health & Science University (US)
- University of Pittsburgh (US)
- University of California, Irvine (US)
- Kaiser Permanente Redwood City Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- American Journal of Rhinology and Allergy
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1177/19458924241308953
- Citations
- 3
- Primary Topic
- Head and Neck Surgical Oncology
- Type
- article
- Field-Weighted Citation Impact
- 6.02